This session explores the evolving paradigm of cardio-renal-metabolic care, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations can improve outcomes in patients with type 2 diabetes and associated co-morbidities. It focuses on mechanisms, patient selection, real-world evidence, and practical strategies to achieve comprehensive heart, kidney, and metabolic protection in routine clinical practice.

Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2i+DPP4i combinations

Engage in a dynamic panel discussion featuring renowned experts, moderated by Dr. Rucha Mehta, as they deliberate on the ongoing relevance of Metformin as the first-line treatment for Type 2 Diabetes Mellitus (T2DM). Diabetes management has recently become more outcomes-focused, shifting from concentrating exclusively on glycemic control to considering the impact these medications have on complications from Diabetes. In this session, these esteemed experts will weigh the pros and cons, exploring the evolving landscape of T2DM management and potential alternatives to Metformin. Join us for an enlightening conversation that addresses the critical question of whether Metformin remains the primary choice in T2DM therapy.

Panel: Is Metformin still the first choice of T2DM?

RCP Diabetology Day-2

Padma Shri Awardee and one of India’s leading endocrinologists. Former President of RSSDI, API, and the Endocrine Society of India, with extensive contributions to diabetes and metabolic health. Renowned clinician, researcher, and educator with over 800 scientific publications

Join us for an insightful session marking 11 years of the landmark EMPA-REG journey and its transformative impact on patient care. This session will explore the robust evidence supporting Empagliflozin and the Empagliflozin + Linagliptin combination across the Cardiovascular-Kidney-Metabolic (CKM) axis, highlighting their role in improving glycaemic control, protecting cardiorenal health, and redefining outcomes for people living with type 2 diabetes. Discover how a decade of evidence continues to shape clinical practice and deliver a lifetime of benefits for patients.

Dr. Shashank Joshi

4

1.6k

56.2k

4.8

Upcoming Sessions

Sessions Taken

942

4.8

828

4.8

0

0